cancer. Malignant neoplasm of stomach, Malignant neoplasm of small intestine, Malignant neoplasm of colon, Malignant neoplasm of rectosigmoid junction, Malignant neoplasm of rectum
Conditions
Interventions
Intervention 1: In the intervention group: gabapentin capsule of 300 milligrams three times a day from one day Chemotherapy will be used until the end of the chemotherapy period. Intervention 2: In th
Treatment - Drugs
In the intervention group: gabapentin capsule of 300 milligrams three times a day from one day Chemotherapy will be used until the end of the chemotherapy period.
In the control group, for the reduction of nausea and vomiting after chemotherapy, a routine of three drugs (dexamethasone, ranitidine and ketril) will be used
Sponsors
Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: : Patients receiving chemotherapy regimen. Exclusion criteria: history of seizure or epilepsy; nausea and vomiting; gabapentin susceptibility; severe illness along with cancer (cardiac, kidney, liver and etc.).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: after intervention. Method of measurement: By grade. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Akbar Shayesteh
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed